1.89
+0.0856(+4.76%)
Currency In USD
| Previous Close | 1.8 |
| Open | 1.82 |
| Day High | 2.14 |
| Day Low | 1.78 |
| 52-Week High | 392 |
| 52-Week Low | 1.78 |
| Volume | 735,979 |
| Average Volume | 646,112 |
| Market Cap | 2.9M |
| PE | -0.1 |
| EPS | -18.82 |
| Moving Average 50 Days | 7.55 |
| Moving Average 200 Days | 78.18 |
| Change | 0.09 |
If you invested $1000 in Conduit Pharmaceuticals Inc. (CDT) since IPO date, it would be worth $1.9 as of February 05, 2025 at a share price of $1.886. Whereas If you bought $1000 worth of Conduit Pharmaceuticals Inc. (CDT) shares 2 years ago, it would be worth $1.83 as of February 05, 2025 at a share price of $1.886.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
GlobeNewswire Inc.
Jan 23, 2025 1:00 PM GMT
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a multi-asset, clinical stage, disease-agnostic life science company delivering an efficient mode
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
GlobeNewswire Inc.
Jan 22, 2025 1:00 PM GMT
Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
GlobeNewswire Inc.
Dec 12, 2024 12:30 PM GMT
Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and clinical trial monitoring. This innovative approach ai